info@synchemia.com | sales@synchemia.com 
9766925136 
Gliclazide EP Impurity B
_1.png)
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Gliclazide is used to treat type 2 diabetes. It's a medicine known as a sulfonylurea. Sulfonylureas increase the amount of insulin your pancreas makes. This lowers your blood sugar.N-Nitroso Gliclazide EP Impurity B is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Gliclazide EP Impurity B chemically represented as 2-Nitroso octahydrocyclopenta[c]pyrrole. Synchemia is the leading manufacturing and exporter of N-Nitroso Gliclazide EP Impurity B.We supply N-Nitroso Gliclazide EP Impurity B with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N0143252 |
| CAS No | NA |
| Mol.F. | C17H21ClN4O5 |
| Mol.Wt. | 396.83 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143253 |
| CAS No | NA |
| Mol.F. | C14H17ClN4O3 |
| Mol.Wt. | 324.77 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143254 |
| CAS No | NA |
| Mol.F. | C20H27ClN4O5 |
| Mol.Wt. | 438.91 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143255 |
| CAS No | NA |
| Mol.F. | C18H25BrN4O4 |
| Mol.Wt. | 441.33 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143256 |
| CAS No | NA |
| Mol.F. | C18H25ClN4O5 |
| Mol.Wt. | 412.87 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143257 |
| CAS No | NA |
| Mol.F. | C26H29Cl2N5O6 |
| Mol.Wt. | 578.45 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143258 |
| CAS No | NA |
| Mol.F. | C18H25ClN4O7 |
| Mol.Wt. | 444.87 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143259 |
| CAS No | NA |
| Mol.F. | C18H25ClN4O5 |
| Mol.Wt. | 412.87 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143260 |
| CAS No | NA |
| Mol.F. | C18H23ClN4O4 |
| Mol.Wt. | 394.86 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143261 |
| CAS No | NA |
| Mol.F. | C10H9ClN2O5 |
| Mol.Wt. | 272.64 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143262 |
| CAS No | NA |
| Mol.F. | C10H8BrClN2O5 |
| Mol.Wt. | 351.54 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143263 |
| CAS No | NA |
| Mol.F. | C26H37N3O6 |
| Mol.Wt. | 487.60g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143264 |
| CAS No | NA |
| Mol.F. | C12H17N3O3 |
| Mol.Wt. | 251.29 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143265 |
| CAS No | NA |
| Mol.F. | C18H29N3O6 |
| Mol.Wt. | 383.45g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143266 |
| CAS No | NA |
| Mol.F. | C19H33N3O6 |
| Mol.Wt. | 399.49 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143267 |
| CAS No | NA |
| Mol.F. | C19H31N3O6 |
| Mol.Wt. | 397.47 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
